TASSETTI, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 551
NA - Nord America 515
AS - Asia 191
AF - Africa 4
Totale 1.261
Nazione #
US - Stati Uniti d'America 515
RU - Federazione Russa 316
IT - Italia 80
IE - Irlanda 72
SG - Singapore 61
SE - Svezia 53
HK - Hong Kong 52
CN - Cina 40
JO - Giordania 20
IN - India 14
DE - Germania 10
GB - Regno Unito 7
CH - Svizzera 6
CI - Costa d'Avorio 4
KR - Corea 4
FI - Finlandia 3
NL - Olanda 2
BE - Belgio 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.261
Città #
Santa Clara 197
Dublin 72
Singapore 56
Chandler 44
Hong Kong 40
Fairfield 21
Florence 21
Altamura 18
Ashburn 18
Lawrence 18
New York 14
Buffalo 12
Moscow 12
Princeton 12
Boston 11
Mumbai 11
Shanghai 11
Beijing 7
Munich 7
Bern 6
San Diego 6
Kent 5
Seattle 5
Woodbridge 5
Abidjan 4
Bologna 4
Cambridge 4
Los Angeles 4
Medford 4
Seoul 4
Hillsboro 3
Houston 3
Lecce 3
Wilmington 3
Yubileyny 3
Campi Bisenzio 2
Cesano Boscone 2
Effeltrich 2
Guangzhou 2
Helsinki 2
Kilburn 2
Livorno 2
Lodi 2
Lurano 2
Milan 2
Redwood City 2
Reggio Emilia 2
Trinitapoli 2
Tukwila 2
Turin 2
Vellore 2
West Jordan 2
Ann Arbor 1
Arezzo 1
Boardman 1
Breendonk 1
Falls Church 1
Grosseto 1
Hagen 1
Hangzhou 1
Košice 1
Lappeenranta 1
London 1
Nanjing 1
Naples 1
Norwalk 1
Pisa 1
Pontedera 1
Pune 1
Southwark 1
Sovizzo 1
Staranzano 1
Washington 1
Wuhan 1
Xingtai 1
Totale 725
Nome #
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 97
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 89
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 88
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 82
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 82
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 79
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 77
Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy 74
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 70
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 67
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 66
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 61
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 57
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 56
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 53
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 53
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 51
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 45
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 38
Totale 1.285
Categoria #
all - tutte 6.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 5 0 4 0
2021/2022109 15 0 3 0 0 6 0 6 16 9 22 32
2022/2023304 17 57 15 12 15 45 48 24 39 6 12 14
2023/2024207 4 17 19 12 11 31 17 50 6 16 13 11
2024/2025656 37 113 64 188 254 0 0 0 0 0 0 0
Totale 1.285